When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA - Scorecard - MDSpire

When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA

  • By

  • J. Noll

  • M. Reichert

  • M. Dietrich

  • J. G. Riedel

  • M. Hecker

  • W. Padberg

  • M. A. Weigand

  • A. Hecker

  • March 21, 2022

  • 0 min

Share

Clinical Scorecard: Timing of Surgical Interventions Following SARS-CoV-2 Infection: An Overview of Recent Guidelines from DGC/BDC and DGAI/BDAI

At a Glance

CategoryDetail
ConditionSARS-CoV-2 infection and its impact on perioperative management
Key MechanismsSARS-CoV-2 binds to ACE2 receptors causing multi-organ involvement; infection induces hyperinflammation, procoagulant state, and immune dysregulation affecting surgical outcomes
Target PopulationPatients with current or past SARS-CoV-2 infection undergoing surgical interventions
Care SettingSurgical and perioperative care settings including elective, emergency, and oncologic surgeries

Key Highlights

  • SARS-CoV-2 infection leads to heterogeneous clinical courses ranging from asymptomatic to critical illness with multi-organ failure.
  • Postoperative complications such as infections and thromboembolic events are major causes of morbidity and mortality, potentially exacerbated by recent SARS-CoV-2 infection.
  • Long Covid syndrome with persistent symptoms can affect surgical risk and timing decisions; optimal timing of elective surgery post-infection is critical.

Guideline-Based Recommendations

Diagnosis

  • Screen patients for current or past SARS-CoV-2 infection prior to surgery, including asymptomatic cases.
  • Consider clinical history and testing limitations due to silent infections.

Management

  • Postpone elective surgeries following SARS-CoV-2 infection to reduce postoperative complications.
  • Use risk scores and primary prophylactic treatments to prevent postoperative complications in infected or recently infected patients.
  • Tailor perioperative management to account for hyperinflammation and procoagulant state induced by SARS-CoV-2.

Monitoring & Follow-up

  • Monitor for postoperative infections and thromboembolic events closely in patients with recent or past SARS-CoV-2 infection.
  • Assess for Long Covid symptoms that may impact recovery and surgical outcomes.

Risks

  • Increased risk of postoperative infections and thromboembolic events due to SARS-CoV-2 induced immune and coagulation changes.
  • Higher mortality and morbidity in patients undergoing surgery during or shortly after SARS-CoV-2 infection.
  • Potential additive negative effects of SARS-CoV-2 infection on surgical outcomes.

Patient & Prescribing Data

Surgical patients with current or prior SARS-CoV-2 infection

Elective surgeries should be timed appropriately post-infection; prophylactic measures against thromboembolism and infections are recommended to improve outcomes.

Clinical Best Practices

  • Delay elective surgery for an optimal period after SARS-CoV-2 infection to minimize postoperative complications.
  • Implement thorough preoperative screening for SARS-CoV-2 infection and Long Covid symptoms.
  • Apply risk stratification tools and prophylactic treatments to mitigate hypercoagulability and inflammation perioperatively.

References

Original Source(s)

Related Content